Previous 10 | Next 10 |
Healthcare stocks are once again in focus as a result of promising news of COVID-19 vaccines. Historically, vaccine success rates are 33% from phase 1 trials to approval. Identifying healthcare companies with strong business models is a much better strategy. For further deta...
We analyze performance trends in closed-end-funds this year along with themes by asset classes. Equity funds with concentrated exposure to Technology and Healthcare are among the biggest winners this year. Energy focused funds have underperformed given the weaker pricing environme...
Written by Nick Ackerman, co-produced by Stanford Chemist Section 19(a) Notices can sometimes confuse or be a bit misleading to investors. This can be especially confusing for newer closed-end fund investors that are just getting started. There are so many terms, to begin within investin...
The art of medicine consists of amusing the patient while nature cures the disease. ― Voltaire At first glance, Tekla World Healthcare Fund ( THW ) looks like a solid dividend bet because it has been paying dividends consistently since inception and it sports an attractive dividend ...
Co-produced with PendragonY Why Invest in Healthcare and Biotech Closed-End Funds? Tekla Healthcare Investors ( HQH ) has been an HDO holding for more than four years, and in April we upgraded it to a "Must Own", in the midst of the COVID-19 outbreak. As a closed-end fund t...
By Harry Domash, DividendDetective and Winning Investing Eventually, a reliable vaccine will be developed, the coronavirus will be history, and we’ll once again be able to pick stocks based on the relatively predictable factors such as revenue and earnings growth, explains ...
Written by Nick Ackerman, co-produced by Stanford Chemist Continuing with our coverage of BlackRock funds, as we had done with Eaton Vance's funds, we will be focusing on BlackRock's sector-focused funds. In today's piece, we will be looking at the healthcare and tech names offered by Bl...
Author's note : This article was released to CEF/ETF Income Laboratory members on June 16, 2020. Please check latest data before investing. Chemist's Closed-End Fund Report Quantitative screens help to rapidly narrow down attractive candidates from the database of 500-plus closed-...
On June 8, 2020, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is June 19, 2020 and the payable date is June 30, 2020. The Fund will trade ex-distribution on June 18, 2020. Note that only ...
Markets have settled and recovered from the initial shock of the coronavirus spread and the response of governments around the US and the world to lock down the economy. But while the major US indices have approached, if not quite matched, the fabled v-shaped recovery, there are still plenty o...
News, Short Squeeze, Breakout and More Instantly...
Tekla World Healthcare Fund Shares of Beneficial Interest Company Name:
THW Stock Symbol:
NYSE Market:
There’s nothing we closed-end fund investors love more than finding a smartly run fund in an unfairly beaten-down sector. This hands us a nice discount (of course!), plus a much bigger dividend, because yields and prices move in opposite directions. In fact, with CEFs, we...
Most investors are ignoring a clear shot at 7%+ dividends double-digit price gains—year in and year out—in a sector everyone should be talking about, but isn’t. That would be healthcare, which is riding a rocket of rising spending: according to the latest number...
Tekla World Healthcare Fund (the “Fund”) (NYSE: THW) is pleased to announce the completion of its one for three non-transferable rights offering (the “Offering”) which expired Tuesday, April 6, 2021 (the “Expiration Date”). Pursuant to the Offer...